To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC49109 | EGFR-IN-24 |
EGFR-IN-24, a potent EGFR inhibitor, shows inhibition against EGFR(del19/T790M/C797S) and EGFR(L858R/T790M/C797S), respectively.
More description
|
|
| DC49108 | HPK1-IN-9 |
HPK1-IN-9 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-9 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 112) .
More description
|
|
| DC49107 | BRD4-BD1/2-IN-2 |
BRD4-BD1/2-IN-2 is a potent BRD4 BD2 inhibitor with IC50s of <0.5 nM and <300 nM for BRD4 BD2 and BRD4 BD1, respectively (WO2021233371A1, compound 2).
More description
|
|
| DC49106 | Mal-Ala-Ala-PAB-PNP |
Mal-Ala-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More description
|
|
| DC49105 | DCN1-UBC12-IN-3 |
DCN1-UBC12-IN-3 is potent and selective DCN1-UBC12 inhibitor with an IC50 of 2.25 nM. Anticardiac fibrotic effect.
More description
|
|
| DC49104 | RET-IN-6 |
RET-IN-6 is a potent RET (rearranged during transfection) inhibitor with an IC50 of 4.57 nM (CN113461670A, compound 321).
More description
|
|
| DC49103 | NCGC00138783 |
NCGC00138783 selectively blocks the CD47/SIRPα interaction with an IC50 value of 40 μM for the cell surface binding. NCGC00138783 does not disrupt its binding to other receptors.
More description
|
|
| DC49102 | Gymconopin C |
Gymconopin C shows an antiallergic effect on ear passive cutaneous anaphylaxis reactions in mice.
More description
|
|
| DC49101 | Morelloflavone |
Morelloflavone has antioxidative, antiviral, and anti-inflammatory properties.
More description
|
|
| DC49100 | Tetracosactide acetate |
Tetracosactide acetate is a synthetic peptide stimulating the release of corticosteroids such as cortisol from the adrenal gland. Tetracosactide acetate is currently used for the research of ulcerative colitis and Crohn's disease, juvenile/adult rheumatoid arthritis and osteoarthrosis.
More description
|
|
| DC49099 | Aluminum Glycinate |
Aluminum Glycinate, an organo-metallic compound, is an antacid. Aluminum Glycinate can be used for the research of indigestion, acid reflux and ulcers.
More description
|
|
| DC49098 | t-Boc-Aminooxy-PEG11-amine |
t-Boc-Aminooxy-PEG11-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
More description
|
|
| DC49097 | Biotin-PEG6-NH-Boc |
Biotin-PEG6-NH-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
More description
|
|
| DC49095 | ABL-L |
ABL-L induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway.
More description
|
|
| DC49094 | Digoxigenin monodigitoxoside |
Digoxigenin monodigitoxoside is a Na+/K+ ATPase inhibitor and cardiac glycoside metabolite of digoxin.
More description
|
|
| DC49093 | ent-Heronamide C |
ent-Heronamide C has antifungal activity and is designed as probe for the mode-of-action analysis of heronamide C.
More description
|
|
| DC49092 | 16,17-Dihydroheronamide C |
16,17-Dihydroheronamide C has antifungal activity and is designed as probe for the mode-of-action analysis of heronamide C.
More description
|
|
| DC49091 | (S)-(-)-MRJF22 |
(S)-(-)-MRJF22 is haloperidol metabolite II valproate ester. (S)-(-)-MRJF22 exhibits the high antimigratory effects in endothelial and tumor cells. (S)-(-)-MRJF22 is a potential multifunctional agent against uveal melanoma.
More description
|
|
| DC49090 | Setosusin |
Setosusin ((+)-Setosusin) is a fungal meroditerpenoid featuring a unique spiro-fused 3(2H)-furanone moiety.
More description
|
|
| DC49089 | Cyanosafracin B |
Cyanosafracin B is a starting material for synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650.
More description
|
|
| DC49088 | EGFR-IN-26 |
EGFR-IN-26 is a EGFR inhibitor extracted from patent WO2019162323A1 compound I-028. EGFR-IN-26 can be used for the research of cancer.
More description
|
|
| DC49087 | KRAS G12C inhibitor 26 |
KRAS G12C inhibitor 26 is a KRAS G12C inhibitor with antitumor effects (WO2021109737).
More description
|
|
| DC49086 | KRAS G12C inhibitor 27 |
KRAS G12C inhibitor 27 is a KRAS G12C inhibitor with antitumor effects (WO2021109737).
More description
|
|
| DC49085 | Bafrekalant |
Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1).
More description
|
|
| DC49084 | Lubabegron |
Lubabegron is a potent modulator of β-adrenergic receptor (β -AR). Lubabegron demonstrates antagonistic behavior at the β1 and β 2 receptor subtypes and agonistic behavior at the β 3 receptor subtype in cattle. Lubabegron reduces NH3 gas emissions from an animal or its waste.
More description
|
|
| DC49081 | RET-IN-5 |
RET-IN-5 is a potent RET (rearranged during transfection) inhibitor with an IC50s of 0.4 nM and 135.1 nM for RET and VEGFR2, respectively (WO2021213476A1, compound 18).
More description
|
|
| DC49080 | ER 50891 |
ER-50891 is a potent antagonist of retinoic acid receptor α(RARα). ER-50891 significantly attenuates ATRA's inhibitive effects on BMP 2-induced osteoblastogenesis.
More description
|
|
| DC49079 | Acid-PEG10-t-butyl ester |
Acid-PEG10-t-butyl ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
More description
|
|
| DC49078 | Phytochelatin 3 TFA |
Phytochelatin 3 (PC 3) TFA is the small metal chelating peptide that can be used for chelating heavy metals.
More description
|
|
| DC49077 | Aszonapyrone A |
Aszonapyrone A is a metabolite produced by Aspergillus zonatus.
More description
|
|